Clinical Trial Detail

NCT ID NCT04220892
Title Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jose Carrillo
Indications

malignant glioma

Therapies

Abemaciclib + Pembrolizumab

Pembrolizumab + Pemetrexed Disodium

Age Groups: senior adult

No variant requirements are available.